Dysplasia Flashcards

1
Q

When after a cone can someone try to conceive

A

6 months to 1 year to decrease risk of PTD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How common is HPV infection

A

85% of sexually active individuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How effective is the vaccine at preventing HPV infection?

A

FUTURE II Study Group NEJM 2007
randomized double bling RCT 12000 women 15-26, all got 3 doses of gardasil 4 or placebo

Followed patients for 3 years: 98% of susceptible population was negative, in ITT (but may have tested positive for HPV early on in study) 44% were negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are side effects from gardasil

A

Severe adverse events are rare: <0.1%
Most common are injection site pain
Deaths were due to car accidents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Whats the difference between the HPV vaccines

A

Gardasil 9: 6, 11, 16, 18, 31, 33, 45, 52, 58 - 98% efficacy
Gardasil: 6 11 16 18 98% efficacy
Cervarix: 16 18 92%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How much does HPV vaccine cost?

A

200 per shot (600 total)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the HPV regimen

A

<15: 0 and 6 months (need 5 months between)
15-26 and immunocompromized (***)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe HPV Vaccine catch up regimen

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the effect of HPV vaccine in patients with dysplasia

A

Lichter et al meta analysis

RCT or cohorts hpv vaccination in patients getting treatment (CKC LEEP or cryo)
recurrence CIN 2 or greater
Recurrence of CIN 1 or greater

Inclusion - at least 1 dose of vaccine, needed treatment and control groups, excluded immunocompromise and malignancy, also excluded pregnant patients

Had 2900 patients in this study
45% got vaccination, 54% did not

REsult:
CIN 2 or higher recurrence: RR 0.36 1.9% recurrence vaccinated, 5.5% unvaccinated (64% reduction)
CIN 1 or higher : 6% in vaccinated, 10% in unvaccinated group (33% reduction)

Limitations: 2 studies account for 60% of data, not all were RCTs, each vaccinated at different time points

Other meta-analyses
CIN 3 or higher : no statistically significant vaccinated 0.6% and unvaccinated 2.2% (only 1100 women in this analysis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why does vaccine work in women with HPV before

A

cross protection across strains not yet exposed to

Change in the immune microenvironment following surgery which may create a new background - new mucosal immune status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What negative margin do you need to pursue fertility sparing

A

3mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly